company background image
NEU logo

NEUCA WSE:NEU Voorraadrapport

Laatste prijs

zł806.00

Marktkapitalisatie

zł3.6b

7D

-1.3%

1Y

11.8%

Bijgewerkt

03 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

NEUCA S.A.

WSE:NEU Voorraadrapport

Marktkapitalisatie: zł3.6b

NEU Overzicht aandelen

NEUCA S.A. houdt zich bezig met de groothandel in farmaceutische producten in Polen.

Over het bedrijf

Beloningen

Trading at 38.4% below our estimate of its fair value
Earnings are forecast to grow 23.44% per year
Earnings have grown 3.2% per year over the past 5 years

Risicoanalyse

Shareholders have been diluted in the past year

NEUCA S.A. Concurrenten

Voxel

WSE:VOX

zł1.2b

Massmedica

WSE:MSM

zł17.5m

Centrum Medyczne ENEL-MED

WSE:ENE

zł565.6m

EMC Instytut Medyczny

WSE:EMC

zł441.1m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor NEUCA
Historische aandelenkoersen
Huidige aandelenkoerszł806.00
52 Week Hoogtepuntzł969.00
52 Week Laagzł705.00
Bèta0.40
11 maand verandering-3.47%
3 maanden verandering4.40%
1 Jaar Verandering11.79%
33 jaar verandering-11.91%
5 jaar verandering118.43%
Verandering sinds IPO1,765.74%

Recent nieuws en updates

NEUCA S.A.'s (WSE:NEU) Intrinsic Value Is Potentially 56% Above Its Share Price

Sep 19
NEUCA S.A.'s (WSE:NEU) Intrinsic Value Is Potentially 56% Above Its Share Price

Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Aug 13
Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Risks To Shareholder Returns Are Elevated At These Prices For NEUCA S.A. (WSE:NEU)

Jul 19
Risks To Shareholder Returns Are Elevated At These Prices For NEUCA S.A. (WSE:NEU)

Recent updates

NEUCA S.A.'s (WSE:NEU) Intrinsic Value Is Potentially 56% Above Its Share Price

Sep 19
NEUCA S.A.'s (WSE:NEU) Intrinsic Value Is Potentially 56% Above Its Share Price

Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Aug 13
Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Risks To Shareholder Returns Are Elevated At These Prices For NEUCA S.A. (WSE:NEU)

Jul 19
Risks To Shareholder Returns Are Elevated At These Prices For NEUCA S.A. (WSE:NEU)

NEUCA (WSE:NEU) Seems To Use Debt Quite Sensibly

Mar 08
NEUCA (WSE:NEU) Seems To Use Debt Quite Sensibly

Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Dec 29
Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Here's Why NEUCA (WSE:NEU) Can Manage Its Debt Responsibly

Dec 05
Here's Why NEUCA (WSE:NEU) Can Manage Its Debt Responsibly

NEUCA (WSE:NEU) Hasn't Managed To Accelerate Its Returns

Apr 16
NEUCA (WSE:NEU) Hasn't Managed To Accelerate Its Returns

An Intrinsic Calculation For NEUCA S.A. (WSE:NEU) Suggests It's 32% Undervalued

Jan 17
An Intrinsic Calculation For NEUCA S.A. (WSE:NEU) Suggests It's 32% Undervalued

Capital Investment Trends At NEUCA (WSE:NEU) Look Strong

Oct 25
Capital Investment Trends At NEUCA (WSE:NEU) Look Strong

Here's Why We Think NEUCA (WSE:NEU) Is Well Worth Watching

Aug 04
Here's Why We Think NEUCA (WSE:NEU) Is Well Worth Watching

Is There An Opportunity With NEUCA S.A.'s (WSE:NEU) 34% Undervaluation?

Jul 01
Is There An Opportunity With NEUCA S.A.'s (WSE:NEU) 34% Undervaluation?

Returns On Capital At NEUCA (WSE:NEU) Have Stalled

Jun 18
Returns On Capital At NEUCA (WSE:NEU) Have Stalled

NEUCA (WSE:NEU) Is Increasing Its Dividend To zł11.50

Apr 21
NEUCA (WSE:NEU) Is Increasing Its Dividend To zł11.50

NEUCA (WSE:NEU) Is Increasing Its Dividend To zł11.50

Apr 07
NEUCA (WSE:NEU) Is Increasing Its Dividend To zł11.50

NEUCA (WSE:NEU) Knows How To Allocate Capital

Mar 15
NEUCA (WSE:NEU) Knows How To Allocate Capital

Does NEUCA (WSE:NEU) Have A Healthy Balance Sheet?

Jan 03
Does NEUCA (WSE:NEU) Have A Healthy Balance Sheet?

Is NEUCA (WSE:NEU) Using Too Much Debt?

Jun 14
Is NEUCA (WSE:NEU) Using Too Much Debt?

With EPS Growth And More, NEUCA (WSE:NEU) Is Interesting

May 19
With EPS Growth And More, NEUCA (WSE:NEU) Is Interesting

Investors Shouldn't Overlook NEUCA's (WSE:NEU) Impressive Returns On Capital

Mar 30
Investors Shouldn't Overlook NEUCA's (WSE:NEU) Impressive Returns On Capital

A Look At The Fair Value Of NEUCA S.A. (WSE:NEU)

Mar 15
A Look At The Fair Value Of NEUCA S.A. (WSE:NEU)

Did You Participate In Any Of NEUCA's (WSE:NEU) Fantastic 211% Return ?

Mar 02
Did You Participate In Any Of NEUCA's (WSE:NEU) Fantastic 211% Return ?

Is Now The Time To Put NEUCA (WSE:NEU) On Your Watchlist?

Feb 18
Is Now The Time To Put NEUCA (WSE:NEU) On Your Watchlist?

Is NEUCA S.A.'s(WSE:NEU) Recent Stock Performance Tethered To Its Strong Fundamentals?

Feb 06
Is NEUCA S.A.'s(WSE:NEU) Recent Stock Performance Tethered To Its Strong Fundamentals?

Should You Rely On NEUCA's (WSE:NEU) Earnings Growth?

Jan 26
Should You Rely On NEUCA's (WSE:NEU) Earnings Growth?

The Case For NEUCA S.A. (WSE:NEU): Could It Be A Nice Addition To Your Dividend Portfolio?

Jan 15
The Case For NEUCA S.A. (WSE:NEU): Could It Be A Nice Addition To Your Dividend Portfolio?

Is NEUCA (WSE:NEU) Using Too Much Debt?

Jan 04
Is NEUCA (WSE:NEU) Using Too Much Debt?

The Trend Of High Returns At NEUCA (WSE:NEU) Has Us Very Interested

Dec 23
The Trend Of High Returns At NEUCA (WSE:NEU) Has Us Very Interested

Is NEUCA S.A. (WSE:NEU) Trading At A 24% Discount?

Dec 13
Is NEUCA S.A. (WSE:NEU) Trading At A 24% Discount?

Could The NEUCA S.A. (WSE:NEU) Ownership Structure Tell Us Something Useful?

Dec 03
Could The NEUCA S.A. (WSE:NEU) Ownership Structure Tell Us Something Useful?

Announcing: NEUCA (WSE:NEU) Stock Increased An Energizing 122% In The Last Three Years

Nov 23
Announcing: NEUCA (WSE:NEU) Stock Increased An Energizing 122% In The Last Three Years

Rendement voor aandeelhouders

NEUPL HealthcarePL Markt
7D-1.3%-0.9%-1.2%
1Y11.8%21.8%3.2%

Rendement versus industrie: NEU underperformed the Polish Healthcare industry which returned 21.8% over the past year.

Rendement versus markt: NEU exceeded the Polish Market which returned 3.2% over the past year.

Prijsvolatiliteit

Is NEU's price volatile compared to industry and market?
NEU volatility
NEU Average Weekly Movement4.7%
Healthcare Industry Average Movement4.1%
Market Average Movement5.0%
10% most volatile stocks in PL Market8.5%
10% least volatile stocks in PL Market3.1%

Stabiele aandelenkoers: NEU has not had significant price volatility in the past 3 months compared to the Polish market.

Volatiliteit in de loop van de tijd: NEU's weekly volatility (5%) has been stable over the past year.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19904,633Piotr Sucharskiwww.neuca.pl

NEUCA S.A. houdt zich bezig met de groothandelsdistributie van farmaceutische producten in Polen. Het is actief via de segmenten Groothandel in geneesmiddelen, Vervaardiging van geneesmiddelen, Medisch operator, Klinische proeven en Verzekeringsactiviteiten. Het bedrijf bezit en produceert Rx, OTC-geneesmiddelen, voedingssupplementen, medische hulpmiddelen, dermocosmetica, hygiëneproducten, persoonlijke beschermingsmiddelen, evenals diagnostische en verbandmiddelen onder de merknamen Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions en Kic Kic aan apothekers, artsen en patiënten.

NEUCA S.A. Samenvatting

Hoe verhouden de winst en inkomsten van NEUCA zich tot de beurswaarde?
NEU fundamentele statistieken
Marktkapitalisatiezł3.61b
Inkomsten(TTM)zł164.59m
Inkomsten(TTM)zł12.13b

21.9x

Koers/Winstverhouding

0.3x

P/S-verhouding

Is NEU overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
NEU resultatenrekening (TTM)
Inkomstenzł12.13b
Kosten van inkomstenzł10.74b
Brutowinstzł1.38b
Overige uitgavenzł1.22b
Inkomstenzł164.59m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 19, 2024

Winst per aandeel (EPS)36.77
Brutomarge11.41%
Nettowinstmarge1.36%
Schuld/Eigen Vermogen Verhouding39.0%

Hoe presteerde NEU op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

1.8%

Huidig dividendrendement

39%

Uitbetalingsratio